| |
|
|
|
|
|
A commonly used laboratory test to confirm the existence of myocardial damage is the measurement of a small fraction of the creatine kinase (CK) enzyme, mass CK-MB (mCK-MB). mCK-MB will not normally be elevated until 6 to 8 hours after the onset of MI.1
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|
|
|
|
|
For patients in need of an early diagnosis, a rapidly appearing biochemical marker (such as Myoglobin) plus a specific marker that rises later (e.g., cTnI) are recommended.1 In addition, Myoglobin has an excellent negative predictive value in the evaluation of patients with acute chest pain.2-6
Myoglobin, a low molecular weight heme protein found in cardiac and skeletal muscle, is valuable in the early evaluation of chest pain patients. It may appear in the blood in abnormal levels as early as 1 to 3 hours after onset of myocardial ischemia. While Myoglobin is not specific to cardiac muscle,
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|
|
|
|
|
Enhancing the Siemens Healthcare Diagnostics leadership position in cardiac markers and enriching an already comprehensive cardiac disease state panel that includes cardiac troponin I, hsCRP and myoglobin, the NT-proBNP assay is used to risk stratify patients with Acute Coronary Syndromes (ACS) and Congestive Heart Failure (CHF), and is also an aid in diagnosing CHF. Now you have even more of a reason to select Siemens for your total cardiac solution.
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|
|
|
|
|
Running STAT ßhCG from whole blood allows for more expeditious clinical decision-making and provision of appropriate care. It eliminates the need for duplicate, confirmatory testing and rapidly provides information to address potential pregnancy complications.
ßhCG on the Stratus® CS STAT Fluorometric Analyzer provides rapid, quantitative results for the early detection of pregnancy from a whole blood sample in as little as 14 minutes.
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|
|
|
|
|
The Triage® Cardiac System is a hand-held, point-of-care diagnostic cardiac marker test capable of detecting an acute myocardial infarction (AMI), commonly known as a heart attack, in about 15 minutes. The Triage® Cardiac Panel provides a rapid, quantitative screen for three cardiac markers, creatine kinase-MB (CK-MB), myoglobin and troponin I, which are released in the blood when an AMI occurs. Developed by Biosite Incorporated, the Triage® Cardiac System consists of two components: the disposable Triage® Cardiac Panel and the portable Triage® Meter, the size of a business telephone, that dis
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|
|
|
|
|
Rapid Cardiac Marker Tests
— To diagnose acute myocardial infarction (MI):
Myoglobin
CK-MB
Troponin I
MLC - Myosin Light Chain
2-in-1 - CK-MB/Myoglobin
2-in-1 - Troponin I/Myoglobin
3-in-1 - CK-MB/Myoglobin/Troponin I
— To diagnose congestive heart failure (CHF):
Nt-proBNP - N-terminal pro-Brain Natriuretic Peptide
— To diagnose congestive heart failure/myocardial infarction (CHF/MI):
D-Dimer
2-in-1 - Nt-proBNP/Troponin I
|
Company:
Date:
December 16, 2008
|
|
|
|
|
|
|
|
|
|
Rapid point-of-care test for the detection of myocardial infarction
Tests for Troponin I, Myoglobin, CK-MB on one cassette
Results in 15 minutes
Reduces potential ER overcrowding
Improves patient care
Reduces unnecessary testing and admission
Simultaneous detection of each cardiac marker is optimal for early detection because they are released at various stages of MI
CPT Codes: 82553, 83874, and 84484
|
Company:
Date:
December 16, 2008
|
|
|
|
|
|
|
|
|
|
Rapid on-site in vitro test for the determination of Troponin I
Device Format: Cassette (single-use)
Sample Medium: Whole blood, serum or plasma
Sample Volume: 130 µL
Result Type: Quantitative (range 0.05–30 ng/mL)
Result Interpretation: Using DXpress™ Reader
Result Time: 15 minutes
Shelf Life: 12 months from the date of manufacture
Storage Temperature: 2–8°C
Regulatory Approval: CE marked for professional use
|
Company:
Date:
December 16, 2008
|
|
|
|
|
|
|
|
|
|
Bestimmung von Troponin T, Myoglobin und CK-MB erlauben eine schnelle Diagnose bei Patienten mit akutem Koronarsyndrom (ACS). Bei Verdacht auf eine tiefe Venenthrombose (TVT) oder eine Lungenembolie (LE) wird auf D-Dimer getestet. NT-ProBNP hilft bei der Diagnose und der Beurteilung von Patienten mit Verdacht auf Herzinsuffizienz.
|
Company:
Date:
December 16, 2008
|
|
|
|
|
|
|
|
|
|
Compact desktop analyzer for fast Point of Care (PoC) diagnosis of patients with acute coronary syndrome, venous thromboembolism and congestive heart failure. For use in doctors’ offices or emergency rooms.
When every minute counts, the Cardiac reader analyzer allows the quantitative determination of troponin T, myoglobin, D-Dimer and now N-terminal proBNP (NT-proBNP) from a single whole blood sample within minutes.
|
Company:
Date:
February 15, 2009
|
|
|
|
|
|